Provider QP37-24 Update for New-to-Market Medical Drugs: atidarsagene autotemcel, crovalimab, and fidanacogene eleparvovec Read More
Provider QP39-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2024 Read More
Provider QP40-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective June 1, 2024 Read More
Provider P35-24 New Medical, Medical Drug and Behavioral Health Policy Management Updates, Effective July 1, 2024 Read More
